FoodOxys PC is a spin-off company of the University of Thessaly, founded in 2019 by Dimitrios Kouretas, Professor of Animal Physiology-Toxicology, and his research team. The primary goal of the company is to translate scientific knowledge into practical products and services to benefit society, while also creating economic surplus value for the University through the high-level scientific research.
FoodOxys offers cutting-edge services in the fields of nutritional wellness and food products and supplements bioactivity, in line with the global emerging trends in precision medicine and individualized nutritional intervention. The company specializes in providing personalized nutritional recommendations based on the assessment of human metabolic profile. Furthermore, FoodOxys has developed a complete set of services for evaluating and promoting the quality of food products and supplements.
The scientific team of FoodOxys consists of distinguished researchers with remarkable experience in the research fields of “Nutritional Biochemistry” and “Human Metabolism”. Under the scientific guidance of Professor Dimitrios Kouretas, FoodOxys scientists have published more than 250 papers in international peer-reviewed scientific journals.
I am a scientist turned entrepreneur, driven by a mission to bring oxidative stress research out of the lab and into people’s lives.
Born in Thessaloniki in 1995, I graduated top of my class in Biochemistry & Biotechnology (2017), completed a Master’s and PhD in Toxicology (2023), with a focus on free radicals and redox balance.
Since 2019, I’ve been leading FoodOxys, a University of Thessaly spin-off backed by Uni.Fund and part of the Elevate Greece innovation ecosystem. I’m also the Managing Director of Olea Fortius, a company exploring the nutrigenomic potential of olive-based extracts.
I’ve authored 30 peer-reviewed articles (h-index 11) and co-authored a book on “Intermittent Fasting and Disease Prevention” (2019). In 2024, I was honored to be included in Forbes 30 Under 30 list for Greece.